Erin Ralston, RN Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: 1105 S Wright Blvd, Liberty Lake, WA 99019 Phone: 509-220-1649 |
Rachel Livingston, RN, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1423 N Molter Rd Unit 542, Liberty Lake, WA 99019 Phone: 208-659-2841 |
Florence Mclaurin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1719 N Winchester Ct, Liberty Lake, WA 99019 Phone: 208-818-1902 |
Rachel Rebecca Burgess, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 21622 E Bitterroot Ln, Liberty Lake, WA 99019 Phone: 901-831-3678 |
Mrs. Kelsey Alexis Smith, RN, IBCLC Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 24111 Cataldo Ct, Liberty Lake, WA 99019 Phone: 206-817-0662 |
News Archive
ImmuNext, Inc., today announced that it has entered into an agreement with Janssen Biotech, Inc., focused on the development of novel therapeutics that modulate the immune system for the treatment of cancer.
Almost everyone knows how it feels to remember things for decades on end – and also how it feels to forget where you left your car keys. The answer to this strange paradox could be simple, according to a new study from Caltech. The researchers found that that the brain recruits a higher number of neurons which fire impulses in a synchronized manner to form and store strong memories over long periods.
Very low doses of a drug used to treat certain types of cancer protect the insulin-producing cells in the pancreas and prevent the development of diabetes mellitus type 1 in mice. The medicine works by lowering the level of so-called sterile inflammation. The findings have been made by researchers from the University of Copenhagen, the Technical University of Denmark and the University of Southern Denmark working with researchers in Belgium, Italy, Canada, Netherlands and the USA.
Pfizer Inc. today announced randomized Phase 2 data that showed PD-0332991 (PD-991) in combination with letrozole significantly extended progression free survival (PFS) compared with letrozole alone in post-menopausal patients with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or metastatic breast cancer.
The American Journal of Preventive Medicine, published by Elsevier, is committed to publishing the most robust, evidence-based research and commentary on COVID-19 as they unfold to keep readers up to date and aware of issues relevant to community and individual health during this continually evolving global outbreak.
› Verified 2 days ago